Spruce Biosciences targets Q4 2026 BLA filing for TA-ERT in MPS IIIBAug 12Quarterly updateSpruce Biosciences
Spruce Biosciences' expanded access program for tralesinidase alfa in MPS IIIB listed as availableJul 29Trial updateSpruce Biosciencestralesinidase alfa
Sign inSign in